Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis
European Journal of Cancer2017Vol. 86, pp. 248–256
Citations Over TimeTop 10% of 2017 papers
Cindy Franklin, Isabelle Rooms, Melanie Fiedler, Henning Reis, Laura Milsch, Saskia Herz, Elisabeth Livingstone, Lisa Zimmer, Kurt Werner Schmid, Ulf Dittmer, Dirk Schadendorf, Bastian Schilling
Related Papers
- → Clinical Benefit from Ipilimumab Therapy in Melanoma Patients may be Associated with Serum CTLA4 Levels(2014)57 cited
- → The Ipilimumab Lesson in Melanoma: Achieving Long-Term Survival(2015)28 cited
- → Ipilimumab in anti-PD1 refractory metastatic melanoma(2015)18 cited
- → Retrospective Analysis of Rechallenge with Ipilimumab in Patients with Metastatic Melanoma(2021)3 cited
- → Treatment Patterns among Advanced Melanoma Patients in Europe(2016)